The Conversation (0)
Interleukin Genetics filed a Form 15 with the Securities and Exchange Commission.
Interleukin Genetics (OTCQB:ILIU) filed a Form 15 with the Securities and Exchange Commission.
As quoted in the press release:
Interleukin Genetics filed a Form 15 with the Securities and Exchange Commission completing the process of delisting and deregistering its securities under the Exchange Act.
The Company announced on July 25, 2017, that it would begin the process of delisting and deregistering its securities and filed a Form 25 on August 4, 2017 as part of the process.
Click here to read the full press release.
Source: globenewswire.com